Table 1.
Metabolic syndrome among control population and breast cancer patients
| Variable | Breast cancer patients | Control population | OR(95%CI);p value | |||||
|---|---|---|---|---|---|---|---|---|
| MS | Non-MS | total | MS | Non-MS | total | |||
| Number (%) | 197(32.6%) | 408(67.4%) | 605 | 584(18.2%) | 2628(81.8%) | 3212 | 2.173(1.793,2.633);p<0.001 | |
| Age, years (mean±SD) | 55.8±9.9 | 47.6±10.6 | 50.3±11.1 | 56±13.1 | 44.4±13.9 | 46.6±14.5 | - | |
| Age stratification, years | ||||||||
| <60 | 116(24.9%) | 350(75.1%) | 466 | 331(13.0%) | 2213(87.0%) | 2544 | 2.216(1.744,2.816);p<0.001 | |
| 18-29 | 3(21.4%) | 11(78.6%) | 14 | 14(3.2%) | 429(96.8%) | 443 | p=0.005* | |
| 30-39 | 4(5.3%) | 71(94.7%) | 75 | 42(6.5%) | 605(93.5%) | 647 | p=0.889* | |
| 40-49 | 44(20.4%) | 172(79.6%) | 216 | 117(14.3%) | 699(85.7%) | 816 | p=0.030 | |
| 50-59 | 65(40.4%) | 96(59.6%) | 161 | 158(24.8%) | 480(75.2%) | 638 | 2.057(1.431,2.956);p<0.001 | |
| ≥60 | 81(58.3%) | 58(41.7%) | 139 | 253(37.9%) | 415(62.1%) | 668 | 2.291(1.580,3.322);p<0.001 | |
| Body mass index (BMI) kg/m2 | ||||||||
| Mean±SD | 25.7±3.4 | 23.1±4.1 | 23.9±5.5 | 25.6±3.1 | 21.8±2.6 | 22.5±3.1 | - | |
| Underweight (BMI<18.5) | 0(0%) | 29(100%) | 29 | 4(1.9%) | 212(98.1%) | 216 | p=1.000* | |
| Normal (18.5≤BMI<25) | 85(22.1%) | 299(77.9%) | 384 | 240(10.1%) | 2132(89.9%) | 2372 | 2.525(1.917,3.326);p<0.001 | |
| Preobese (25≤BMI<30) | 91(57.6%) | 67(42.4%) | 158 | 298(52.7%) | 268(47.3%) | 566 | p=0.270 | |
| Obesity (BMI≥30) | 21(61.8%) | 13(38.2%) | 34 | 42(72.4%) | 16(27.6%) | 566 | p=0.289 | |
*Continuity Correction Chi-Square Test.